Track topics on Twitter Track topics that are important to you
NICE, France, June 2, 2015 (GLOBE NEWSWIRE) -- At TM Forum Live! in Nice, Amdocs (Nasdaq:DOX), the leading provider of customer experience solutions, today announced the launch of Amdocs CES 9.3, the company's latest portfolio release introducing new solutions for online commerce, interactive bills, big data marketing, care and network analytics, as well as cross-portfolio enhancements to improve system performance. As a result, service providers are able to inspire customers with exciting services, create intelligent interactions and deliver a dynamic quality of experience, all the while accelerating business value.
Amdocs CES 9.3 spans industry-specific business and operational support systems (B/OSS) and network control and optimization systems. Continuing to build on strong portfolio integration, Amdocs CES 9.3 enables service providers to respond to the multi-dimensional market demands that are driving The New World of Customer Experience, an era where service providers are expected to offer innovative and personalized services, delivered consistently across channels and with a seamless network service experience. This latest portfolio release also accelerates business value for service providers by streamlining complex operating environments, driving cost reduction and speeding time to market for new products and services.
Amdocs CES 9.3 highlights include:
Enabling exciting new digital services with a consistent, omni-channel experience:
Personalized experiences, delivered intelligently:
Dynamic quality of experience:
Accelerated business value through operational efficiencies:
"Customers have become more tech-savvy. They expect service providers to constantly raise the innovation bar with new digital services, while providing better network service, a more personalized customer experience and complete information consistency across channels. And they want control over the whole process," said Mark Mortensen, BSS Practice Head at Analysys Mason. "Integrated suites, such as Amdocs CES 9.3, can ensure the delivery of such a customer-controlled high-quality experience across all these dimensions. It is not just about incrementally making things better – to thrive and grow, the traditional communications service providers of today must become the digital service providers of tomorrow."
"Addressing customer experience across all these multiple dimensions adds further complexity to service providers' already complex systems environments, especially when business agility is critical to addressing new regulations and heightened competition from consolidated players and over-the-top entrants," said Chris Williams, head of global marketing at Amdocs. "It's therefore critical for service providers to find ways to introduce operational efficiencies and accelerate business value. Amdocs CES 9.3 delivers cross-portfolio enhancements which improve systems performance, ensuring our customers can offer new services in a timely manner amidst this complexity, while lowering operational costs."
Agora 2 - Level 2, MR10-MR11
For more than 30 years, Amdocs has ensured service providers' success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control and optimization product portfolio with value-driven professional services and managed services operations. With revenue of $3.6 billion in fiscal 2014, Amdocs and its more than 22,000 employees serve customers in over 80 countries.
Amdocs: Embrace Challenge, Experience Success.
For more information, visit Amdocs at www.amdocs.com
Amdocs' Forward-Looking Statement
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2014 filed on December 8, 2014 and our quarterly 6-K form furnished on February 9 and May 11, 2015.
CONTACT: Media Contact: Sara Preto Fusion PR for Amdocs Tel: +1-212-651-4214 E-Mail: email@example.comNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...